Cargando…
Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus
A durable normoglycemic state was observed in several studies that treated type 2 diabetes mellitus (T2DM) patients through metabolic surgery, intensive therapeutic intervention, or significant lifestyle modification, and it was confirmed that the functional β-cell mass was also restored to a normal...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987695/ https://www.ncbi.nlm.nih.gov/pubmed/35385632 http://dx.doi.org/10.4093/dmj.2021.0377 |
_version_ | 1784682799901442048 |
---|---|
author | Kim, Jinyoung Kwon, Hyuk-Sang |
author_facet | Kim, Jinyoung Kwon, Hyuk-Sang |
author_sort | Kim, Jinyoung |
collection | PubMed |
description | A durable normoglycemic state was observed in several studies that treated type 2 diabetes mellitus (T2DM) patients through metabolic surgery, intensive therapeutic intervention, or significant lifestyle modification, and it was confirmed that the functional β-cell mass was also restored to a normal level. Therefore, expert consensus introduced the concept of remission as a common term to express this phenomenon in 2009. Throughout this article, we introduce the recently updated consensus statement on the remission of T2DM in 2021 and share our perspective on the remission of diabetes. There is a need for more research on remission in Korea as well as in Western countries. Remission appears to be prompted by proactive treatment for hyperglycemia and significant weight loss prior to irreversible β-cell changes. T2DM is not a diagnosis for vulnerable individuals to helplessly accept. We attempt to explain how remission of T2DM can be achieved through a personalized approach. It may be necessary to change the concept of T2DM towards that of an urgent condition that requires rapid intervention rather than a chronic, progressive disease. We must grasp this paradigm shift in our understanding of T2DM for the benefit of our patients as endocrine experts. |
format | Online Article Text |
id | pubmed-8987695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Korean Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-89876952022-04-13 Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus Kim, Jinyoung Kwon, Hyuk-Sang Diabetes Metab J Review A durable normoglycemic state was observed in several studies that treated type 2 diabetes mellitus (T2DM) patients through metabolic surgery, intensive therapeutic intervention, or significant lifestyle modification, and it was confirmed that the functional β-cell mass was also restored to a normal level. Therefore, expert consensus introduced the concept of remission as a common term to express this phenomenon in 2009. Throughout this article, we introduce the recently updated consensus statement on the remission of T2DM in 2021 and share our perspective on the remission of diabetes. There is a need for more research on remission in Korea as well as in Western countries. Remission appears to be prompted by proactive treatment for hyperglycemia and significant weight loss prior to irreversible β-cell changes. T2DM is not a diagnosis for vulnerable individuals to helplessly accept. We attempt to explain how remission of T2DM can be achieved through a personalized approach. It may be necessary to change the concept of T2DM towards that of an urgent condition that requires rapid intervention rather than a chronic, progressive disease. We must grasp this paradigm shift in our understanding of T2DM for the benefit of our patients as endocrine experts. Korean Diabetes Association 2022-03 2022-03-24 /pmc/articles/PMC8987695/ /pubmed/35385632 http://dx.doi.org/10.4093/dmj.2021.0377 Text en Copyright © 2022 Korean Diabetes Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Kim, Jinyoung Kwon, Hyuk-Sang Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus |
title | Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus |
title_full | Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus |
title_fullStr | Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus |
title_full_unstemmed | Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus |
title_short | Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus |
title_sort | not control but conquest: strategies for the remission of type 2 diabetes mellitus |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987695/ https://www.ncbi.nlm.nih.gov/pubmed/35385632 http://dx.doi.org/10.4093/dmj.2021.0377 |
work_keys_str_mv | AT kimjinyoung notcontrolbutconqueststrategiesfortheremissionoftype2diabetesmellitus AT kwonhyuksang notcontrolbutconqueststrategiesfortheremissionoftype2diabetesmellitus |